Latisse... The First FDA Approved Prescription Lash Grower

Allergan, the makers of Botox®Cosmetic have just released Latisse. It's the first and only prescription treatment approved by the FDA for inadequate or insufficient eyelashes, growing them longer, fuller, and darker.

Click On Image to Enlarge Latisse at Week 1, Week 8, and Week 16

Think of all the money you spend each year on mascara, over the counter eyelash enhancers, and the most costly of all, eyelash extensions.

Now thanks to ALLERGAN… YOU CAN GROW YOUR OWN!!

Here's how is works:

It's called bimatoprost. It is the active ingredient in Latisse. Research suggests that the additional growth of eyelashes occurs by increasing the percent of hairs in, and the duration of, the anagen (or growth) phase of the hair. Lashes can grow longer, thicker and darker because bimatoprost can prolong this growth phase.

Latisse is available ONLY through a physician. It is sold in 30 day "kits", and is applied once daily to the base of the upper eyelids via the supplied sterile applicators. The effects are not immediate. Clinical studies showed patients' eyelashes beginning to improve at 4 weeks with full results apparent at 16 weeks (as seen above). All patients in the clinical study showed some improvement, and over 78% showed results similar to the photo above. Latisse may also offer some hope for those who have lost their lashes because of chemotherapy.

Latisse..Simple Application!!!

When you're ready to join everyone on the journey to achieving those beautiful sexy cat eyes, please give us a call.

We can give you pricing and set up your free consultation.

SAVE MONEY

If you would like to enhance your appearance or if you simply have questions, please contact us. Dr. Howard L. Brooks is Washington DC's Top Cosmetic Dermatologists' and a leading expert in complexion blending, facial correction and dermatology ( click here to see our before and after pictures). You can turn back the hands of time with facial transformation: Botox, Juvederm, Radiesse, Dysport, Perlane, Restylane, Latisse , please call us today for your complimentary consultation. We would like to provide you with the most current information on skincare and help you achieve the best results.

Please Read This Article:

By Miranda Hitti
WebMD Health News

Dec. 26, 2008 -- The FDA has approved Latisse, the first drug to promote eyelash growth, according to Allergan, the company that makes Latisse.

Latisse, which will be available by prescription starting in the first quarter of 2009, contains the active ingredient of the glaucoma drug Lumigan, which is also made by Allergan.

Eyelash growth is a known side effect of Lumigan. But Lumigan and Latisse are used differently. Lumigan is an eyedrop, and Latisse gets dabbed along the lash line on the upper eyelids to promote longer, thicker, darker lashes.

Allergan states that "Latisse users can expect to experience longer, fuller, and darker eyelashes in as little as eight weeks, with full results in 16 weeks." If Latisse is stopped, eyelashes will gradually return to their previous appearance as new eyelashes grow in.

Allergan also notes that Latisse may cause darkening of the eyelid skin, which may be reversible, and it "may also cause increased brown pigmentation of the colored part of the eye, which is likely to be permanent."

Latisse may also promote hair growth in other skin areas that it frequently touches, so Allergan recommends blotting it off any skin other than the upper eyelid's lash line to prevent that side effect.

According to Allergan, Latisse was well-tolerated in its clinical trials, with the most common side effects being eye redness, itchy eyes, and skin hyperpigmentation.

Earlier this month, and the FDA advisory panel recommended that the FDA approve Latisse and also recommended further studies in certain groups of patients, such as young patients and people who lost their eyelashes to chemotherapy.